Oculocutaneous albinism

Archives of Disease in Childhood

Volumn 80, Issue 6, 1999, Pages 565-569

  Biswas, S ^a   Lloyd, I C ^a  

^a MANCHESTER ROYAL EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOPA; MELANIN; MONOPHENOL MONOOXYGENASE; TYROSINE;

AUTOSOMAL RECESSIVE INHERITANCE; CHEDIAK HIGASHI SYNDROME; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EYE; HAIR; HYPOPIGMENTATION; IRIS; MELANOGENESIS; MELANOSOME; NYSTAGMUS; OCULOCUTANEOUS ALBINISM; OPTIC CHIASM; PHOTOPHOBIA; PRIORITY JOURNAL; RETINA FOVEA; REVIEW; SKIN; VISUAL ACUITY;

EID: 0032988192     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.80.6.565     Document Type: Review

References (49)

1. 1 Guillery RW, Okoro AN, Witkop CJ. Abnormal visual pathways in the brain of a human albino. Brain Res 1975;96:373-7.
2. 2 Kwon BS, Haq AK Pomerantz SH, Halaban R. Isolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus. Proc Natl Acad Sci USA 1987;84:7473-7.
3. 3 Cohen T, Muller RM, Tomita Y, Shibahara S. Nucleotide sequence of the cDNA encoding human tyrosinase-related protein. Nucleic Acids Res 1990;18:2807-8.
4. 4 Jackson IJ, Chambers DM, Tsukamoto K, et al. A second tyrosinase-related protein, TRP-2, maps to and is mutated at the mouse slaty locus. EMBO J 1992;11:527-35.
5. 5 Halaban R, Moellmann G. Murine and human b locus pigmentation genes encode a glycoprotein (gp75) with catalase activity. Proc Natl Acad Sci USA 1990;87:4809-13.
6. 6 Winder A, Kobayashi T, Tsukamoto K, et al. The tyrosinase gene family: interactions of melanogenic proteins to regulate melanogenesis. Cell Mol Biol Res 1994;40:613-26.
7. 7 Giebel LB, Strunk KM, Spritz RA. Organisation and nucleotide sequence of the human tyrosinase gene and a truncated tyrosinase pseudogene. Genomics 1991;9:435-45.
8. 8 Ponnazhagan S, Hou L, Kwon BS. Structural organisation of the human tyrosinase gene and sequence analysis and characterisation of its promoter region. J Invest Dermatol 1994;102:744-8.
9. 9 Murty VVVS, Bouchard B, Mathew S, Vijayasaradhi S, Houghton AN. Assignment of the human TYRP (brown) locus to chromosome region 9p23 by nonradioactive in situ hybridisation. Genomics 1992;13:227-9.
10. 10 Bouchard B, Del Marmol V, Jackson IJ, Cherif D, Dubertret L. Molecular characterisation of a human tyrosinase-related-protein-2 cDNA: patterns of expression in melanucytic cells. Eur J Biochem 1994;219:127-34.
11. 11 King RA, Hearing VJ, Creel DJ, Oetting WS. Albinism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease, Vol. II, 7th ed. New York: McGraw Hill, 1995:4353-92.
12. 12 Nance WE, Jackson CE, Witkop CJ. Amish albinism: a distinctive autosomal recessive phenotype. Am J Hum Genet 1970;22:579-86.
13. 13 Summers CG, King RA. Ophthalmic features of minimal pigment oculocutaneous albinism. Ophthalmology 1994; 101:906-14.
14. 14 Ramsay M, Colman M, Stevens G, et al. The tyrosinase-positive oculocutaneous albinism locus maps to chromosome 15q11.2-12. Am J Hum Genet 1992;51:879-84.
15. 15 King RA, Witkop CJ, Jr. Hairbulb tyrosinase activity in oculocutaneous albinism. Nature 1976;263:69-71.
16. 16 Lee S-T, Nicholls RD, Bundey S, Laxova R, Musarella M, Spritz RA. Mutations of the P gene in oculocutaneous albinism, ocular albinism, and Prader-Willi syndrome plus albinism. N Engl J Med 1994;330:529-34.
17. 17 Boissy RE, Nordlund JJ. Molecular basis of congenital hypopigmentary disorders in humans: a review. Pigment Cell Res 1997;10:12-24.
18. 18 Colello RJ, Jeffery G. Evaluation of the influence of optic stalk melanin on the chiasmatic pathways in the developing rodent visual system. J Comp Neurol 1991;305:304-12.
19. 19 Wang L-C, Dani J, Godement P, Marcus RC, Mason CA. Crossed and uncrossed retinal axons respond differently to cells of the optic chiasm midline in vitro. Neuron 1995;15: 1349-64.
20. 20 Marcus RC, Wang L-C, Mason CA. Retinal axon divergence in the optic chiasm: midline cells are unaffected by the albino mutation. Development 1996;122:859-68.
21. 21 Guillery RW. Why do albinos and other hypopigmented mutants lack normal binocular vision, and what else is abnormal in their central visual pathways? Eye 1996;10: 217-21.
22. 22 Jeffery G. The albino retina: an abnormality that provides insight into normal retinal development. Trends Neurosci 1997;20:165-9.
23. 23 Creel DJ, Witkop CJ, King RA. Asymmetric visual evoked potentials in human albinos. Invest Ophthalmol 1974;13: 430-40.
24. 24 Kriss A, Russell-Eggitt I, Harris CM, Lloyd IC, Taylor D. Aspects of albinism. Ophthalmol Peadiatr Genet 1992;13: 89-100.
25. 25 Creel DJ, Bendel CM, Wiesner GL, et al. Abnormalities of the central visual pathways in Prader-Willi syndrome associated with hypopigmentation. N Engl J Med 1986;314: 1606-9.
26. 26 Roy M-S, Milot JA, Polomeno RC, Barsoum-Homsy M. Ocular findings and visual evoked potential response in the Prader-Willi Syndrome. Can J Ophthalmol 1992;27:307-12.
27. 27 Meienberg O, Hemphill G, Rosenberg M, Hoyt WF. Visually evoked response asymmetries in a family with congenital nystagmus. Arch Neurol 1980;37:697-8.
28. 28 Fitzgerald BA, Billson FA. Dissociated vertical deviation: evidence of abnormal visual pathway projection. Br J Ophthalmol 1984;68:801-6.
29. 29 Tremblay F, De Becker I, Cheung C, La Roche GR. Invest Ophthalmol Vis Sci 1996;37:1784-92.
30. 30 Kriss A, Timms A, Elston J, Taylor D, Gresty M. Visual evoked potentials in DVD: a reappraisal. Br J Ophthalmol 1989;73:265-70.
31. 31 Shallo-Hoffmann J, Apkarian P. Visual evoked response asymmetry only in the albino member of a family with congenital nystagmus. Invest Ophthalmol Vis Sci 1993;34:682-9.
32. 32 Fitzgerald K, Cibis GW. The value of flash evoked potentials in albinism. J Pediatr Ophthalmol Strabismus 1994;31:18-25.
33. 33 Curran RE, Robb RM, Isolated foveal hypoplasia. Arch Ophthalmol 1976;94:48-50.
34. 34 Mietz H, Green WR, Wollf SM, Abundo GP. Foveal hypoplasia in complete oculocutaneous albinism. Retina 1992;12:254-60.
35. 35 Gregor Z. The perifoveal vasculature in albinism. Br J Ophthalmol 1978;62:554-7.
36. 36 Kinnear PE, Jay B, Witkop JR. Albinism. Surv Ophthalmol 1985;30:75-101.
37. 37 King RA, Lewis RA, Townsend D, Zelickson A, Olds DP, Brumbaugh J. Brown oculocutaneous albinism: clinical, ophthalmological, and biochemical characterisation. Ophthalmology 1986;92:1496-505.
38. 38 Collewijn H, Apkarian P, Spekreijse H. The ocular motor behaviour of human albinos. Brain 1985;108;1-28.
39. 39 Abadi RV, Pascal E . Periodic alternating nystagmus in humans with albinism. Invest Ophthalmol Vis Sci 1994;35: 4080-6.
40. 40 Abadi RV, Pascal E. Visual revolution limits in albinos. Vision Res 1991;31:1445-7.
41. 41 Gradstein L, Reinecke RD, Wizov SS, Goldstein HP. Congenital periodic alternating nystagmus. Diagnosis and management. Ophthalmology 1997;104:918-29.
42. 42 Apkarian P, Reits D. Global stereopsis in human albinos. Vision Res 1989;71:355-67.
43. 43 Cobo-Lewis AB, Siatkowski RM, Lavina AM, Marquez LC. Poor stereopsis can support size constancy in albinism. Invest Ophthalmol Vis Sci 1997;38:2800-9.
44. 44 Tressider J, Fielder AR, Nicholson J. Delayed visual maturation: ophthalmic and neurodevelopmental aspects. Dev Med Child Neurol 1990;32:872-81.
45. 45 Lambert SR, Kriss A, Taylor D. Delayed visual maturation: a longitudinal clinical and electrophysiological assessment. Ophthalmology 1989;96:524-9.
46. 46 Fielder AR, Evans NM. Is the geniculostriate system a prerequisite for nystagmus. Eye 1988;2:628-35.
47. 47 Taylor AM, Jeffery G, Lieberman AR. Subcortical afferent and efferent connections of the superior colliculus in the rat and comparisons between albino and pigmented strains. Exp Brain Res 1986;62:131-42.
48. 48 Cocker KD, Moseley MJ, Stirling HF, Fielder AR. Delayed visual maturation: pupillary responses implicate subcortical and cortical visual systems. Dev Med Child Neurol 1998;40: 160-2.
49. 49 Fulcher T, O'Keefe M, Bowell R, et al. Intellectual and educational attainment in albinism. J Pediatr Ophthamol Strabismus 1995;32:368-72.